|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/75 | |
| C07D 213/81 | |||
| C07D 213/82 | |||
| C07D 401/10 | |||
| C07D 401/12 | |||
| C07D 401/14 | |||
| C07D 403/12 | |||
| C07D 409/12 | |||
| C07D 413/14 | |||
| C07D 471/04 | |||
| A61K 31/437 | |||
| A61P 7/02 |
| (11) | Number of the document | 2105436 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09075313.8 |
| Date of filing the European patent application | 2002-09-17 | |
| (97) | Date of publication of the European application | 2009-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2012-02-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 324165 P | 2001-09-21 | US |
| (72) |
Pinto, Donald, US
Quan, Mimi, US
Orwat, Michael, US
Li, Yun-Long, US
Han, Wei, US
Qiao, Jennifer X, US
Lam, Patrick, US
Koch, Stephanie, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543-4000,
US
|
| (54) | Lactam-containing compounds and derivatives thereof as factor XA inhibitors |
| Lactam-containing compounds and derivatives thereof as factor XA inhibitors |